Emmanuelle Hugentobler MD

Emmanuelle Hugentobler, MD has a wide-ranging work experience in various pharmaceutical and medical companies. Emmanuelle'slatest position was as Vice President of Scientific Affairs at Humacyte, which they joined in November 2021. Prior to this, from 2018 to 2021, they held the position of Vice President of Medical Affairs at Kiniksa Pharmaceuticals. Before that, they worked at Avanir Pharmaceuticals as Senior Director in Scientific Communications from 2016 to 2018, and at BelaV Medical Partners as Vice President of Global Medical Director from 2014 to 2016. From 2006 to 2013, they served as Executive Director of Scientific Communications at Optimer Pharmaceuticals. And before Optimer, from 2003 to 2006, they worked at McCann Healthcare, where they held two different roles as Senior Vice President of Medical Director and Management Supervisor of Cardiology Franchise Team Lead.

Emmanuelle Hugentobler, MD earned their Doctor of Medicine (MD) degree from the University of Medicine Paris-Diderot Paris 7. Emmanuelle later completed a residency/fellowship program in Cardiovascular Diseases at the University of Medicine Cochin Paris 5. No further information is provided about their education history.